Consistency of LGE-MRI Fibrosis and EAM Low-voltage Area
Exploratory Study of Consistency of Bi-Atrial Fibrosis Detected by Late Gadolinium Enhancement Magnetic Resonance Imaging and Low Voltage Area of Electroanatomic Mapping
1 other identifier
observational
50
1 country
1
Brief Summary
This study aims to:
- 1.Assess the consistency of LGE-MRI bi-atrial fibrosis and electroanatomical mapping of bi-atrial low voltage region
- 2.To evaluate the electroanatomical characteristics of different types of fibrosis (dense fibrosis, patchy fibrosis, etc.) in different locations of the left and right atrium;
- 3.To explore the correlation between preoperative and postoperative bi-atrial fibrosis and long-term recurrence in patients with atrial fibrillation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 11, 2024
CompletedFirst Posted
Study publicly available on registry
August 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedAugust 14, 2024
August 1, 2024
9 months
August 11, 2024
August 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Consistency of LGE-MRI fibrosis and EAM low-voltage area
Use Registration to match the corresponding spatial points of LGE-MRI and EAM。Each spatial points will contain two types of status(Fibrosis: Yes/No, Low-voltage area: Yes/No). Chi-square test will be used to assess the consistency of fibrosis and low-voltage area.
Baseline (at recruit time point)
Study Arms (1)
Observational Group
Inclusion Criteria 1. Adult patients (≥18 years old) who are willing to participate in this study and can sign informed consent; 2. Atrial fibrillation was diagnosed and catheter ablation was proposed Exclusion criteria a) Left atrial thrombus or left atrial appendage thrombus; b) Severe chronic obstructive pulmonary disease (FEV1/ FVC\<70%, FEV1\<50% predicted value); c) Absolute contraindications of anticoagulation therapy; d) Currently pregnant; e) Contraindications for LGE-MRI (claustrophobia, pacemaker implantation, eGFR\<30ml/min for renal insufficiency, severe obesity, pregnancy, gadolinium chelating agent allergy, etc.); f) refuse to participate in the study; g) other physical or mental incapacity to participate in the study.
Interventions
Participants will receive LGE-MRI scan before catheter ablation and 3 months after catheter ablation
Eligibility Criteria
Adult AF patients who are planned to receive catheter ablation and have no contraindications of LGE-MRI
You may qualify if:
- Adult patients (≥18 years old) who are willing to participate in this study and can sign informed consent;
- Atrial fibrillation was diagnosed and catheter ablation was proposed
You may not qualify if:
- Left atrial thrombus or left atrial appendage thrombus;
- Severe chronic obstructive pulmonary disease (FEV1/ FVC\<70%, FEV1\<50% predicted value);
- Absolute contraindications of anticoagulation therapy;
- Currently pregnant;
- Contraindications for LGE-MRI (claustrophobia, pacemaker implantation, eGFR\<30ml/min for renal insufficiency, severe obesity, pregnancy, gadolinium chelating agent allergy, etc.);
- refuse to participate in the study;
- other physical or mental incapacity to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fuwai Hospital, CAMS&PUMC
Beijing, Beijing Municipality, 100037, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2024
First Posted
August 14, 2024
Study Start
April 1, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
August 14, 2024
Record last verified: 2024-08